2008 BIO International Convention Session List
Click here to search this conference.
Purchase Access to all sessions or buy by the Breakout Session Track and you are guaranteed to gain insight into biotechnology business issues from world-renowned speakers and panelists on global issues and discoveries.
Media
Legend |
|
MP3 | 
|
Handout | 
|
Audio
Synched to PowerPoint |
|
Video
Synched to PowerPoint |
Display sessions grouped by:
Track:
Super Sessions
Bench to Products
Bioethics
Biomarkers
Business Development
Clinical Research/Clinical Trials
Devices and Predictive Diagnostics
Doing Business Globally
Drug Discovery and Development
Emerging Company Issues
Finance
Food and Agriculture
Global Health
Growing the Biotech Workforce
Industrial and Environmental
Intellectual Property/Legal
International Case Studies
Manufacturing
Policy
Public Relations/Investor Relations
Regenerative Medicine
Regulatory
Technology Transfer/Licensing
Super Sessions
Not available separately. Available only as part of the Complete Set.
To purchase the G. Steven Burrill State-of-the-Industry Report book, "Life Sciences: A 20/20 Vision to 2020", Click Here....
Bench to Products
Purchase this track for $95
"The session will deal with novel emerging therapeutic modalities to address medical needs that cannot be met by existing therapeutic approaches. The opportunities to
complement some established modalities and the challenges
in building business around new therapeutic strategies will be discu...
Bioethics
Purchase this track for $95
"When developing new approaches or options to treat disease, it is key that the industry establish and nurture its relationships with target patient organizations, their leaders and members. Exchanging information and providing education about disease
intervention and program development pave ...
Biomarkers
Purchase this track for $95Business Development
Purchase this track for $95
Recent alliances for late-stage compounds have broken through traditional barriers. These include deal economics, joint responsibility for development and concurrent funding of multiple indications. This session will review several of the breakthrough deals of 2007.
Objective1: Prepare for the ma...
Clinical Research/Clinical Trials
Purchase this track for $95
"FDA and the pharma/biotech industry are being compelled by Congress, healthcare payors and patients to be more transparent with respect to the conduct and outcomes of clinical trials, including through the new clinical trial registry requirements of the Food and Drug Administration
Amendments...
Devices and Predictive Diagnostics
Purchase this track for $95
"Next-generation molecular diagnostics represent a rapidly growing field with transformative potential for cancer management and medical practice. Possible clinical
applications range from screening of asymptomatic individuals to predicting the risk of recurrence or response to therapy to surv...
Doing Business Globally
Purchase this track for $95
Where are companies in this industry investing in growth, and why? How are industry clusters developing, and what critical issues or benefits are driving these location decisions by the executives as they choose where to invest? What are the U.S. states and cities doing to compete with other countri...
Drug Discovery and Development
Purchase this track for $95
"The pharmaceutical industry is facing a continued decline in the productivity of new drug approvals—especially evident in new molecules designed to modulate "unprecedented" targets. Participants in this panel will discuss the factors contributing to clinical stage attrition and...
Emerging Company Issues
Purchase this track for $95
"Companies filing their first NDA or BLA have a significantly lower likelihood of receiving first-cycle approval. Some factors contributing to this fact were discussed in an independent evaluation of FDA's first-cycle review performance, conducted by Booz Allen and currently being updated. This...
Finance
Purchase this track for $95
Whether private or public, early or late stage, management teams and shareholders are turning to debt more often to lower their cost of capital and extend cash runways. Panel members representing equipment and growth lending, royalty financing, receivables financing and venture capital will offer pe...
Food and Agriculture
Purchase this track for $95
The panel discussion will start with the tech providers' progress on implementation of the Excellence in Stewardship Programs and how it has brought in the grain handlers, food processors and regulators.
Objective1:Raise awareness of progress in implementing stewardship processes.
Objective2:D...
Global Health
Purchase this track for $95
"Many disease areas have high incidence and great unmet medical needs in developing countries. From a company's perspective, there is a balance to be struck between developing a drug to help alleviate the disease burden in these countries and return on investment to ensure the business can surv...
Growing the Biotech Workforce
Purchase this track for $95
"The adverse financial impact of workplace injuries and resulting loss of key talent and diminished morale can be more devastating than the failure of an investigational product. Yet workplace safety issues tend to suffer from a relative lack of attention until injuries manifest themselves. Thi...